An assessment of early response to targeted therapy via molecular imaging: A pilot study of 3'-deoxy-3'[(18)F]-fluorothymidine positron emission tomography 18F-FLT PET/CT in prostate adenocarcinoma
Dive into the research topics of 'An assessment of early response to targeted therapy via molecular imaging: A pilot study of 3'-deoxy-3'[(18)F]-fluorothymidine positron emission tomography 18F-FLT PET/CT in prostate adenocarcinoma'. Together they form a unique fingerprint.